17.04 USD
▲+0.01+0.06%
盘后 17.05 +0.06%
2026-09-15
市值
$884.70M
市盈率
16.30
EPS
1.04
股息率
—
52 周区间
13.08 – 21.03
成交量
403.74K
Beta
0.24
目标价
17.67
52W 低 13.0852W 高 21.03
价格走势
公司简介
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. fo...